To assess the effects of the CRC-associated mutations in this more physiologically relevant cellular context, we used retroviral expression to generate stable DLD1 human CRC cells coexpressing full-length EphB1 and GFP (Fig. 6A). The gene discussed is EPHB1; the disease is colorectal carcinoma.